Search research articles
Contact Us
Filters
Showing results (411-420 of 508) with videos related to
Page
of 51
Sort By:
Plos Genetics
|
September 16, 2016
The Genetic Basis of Host Preference and Resting Behavior in the Major African Malaria Vector, Anopheles arabiensis
Bradley J Main, Yoosook Lee, Heather M Ferguson, et al.
Plos Pathogens
|
April 21, 2017
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation
Rajesh T Gandhi, Deborah K McMahon, Ronald J Bosch, et al.
American Journal of Epidemiology
|
September 18, 1999
Risk factors for HIV-1 shedding in semen
C E Speck, R W Coombs, L A Koutsky, et al.
Journal of Neuro-Aids
|
January 1, 1996
Neurologic Manifestations<br />of HIV Infection Without AIDS:Follow-UP of a Cohort<br />of Homosexual and Bisexual Men
C M Marra, W T Longstreth, H H Handsfield, et al.
Plos One
|
May 19, 2010
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection
Eric S Rosenberg, Barney S Graham, Ellen S Chan, et al.
The New England Journal of Medicine
|
April 18, 1996
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group
A C Collier, R W Coombs, D A Schoenfeld, et al.
The Journal of Infectious Diseases
|
August 23, 2003
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease
Margaret A Fischl, Heather J Ribaudo, Ann C Collier, et al.
The Journal of Infectious Diseases
|
August 11, 1998
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data
J P Ioannidis, A C Collier, D A Cooper, et al.
Journal of Virology
|
July 31, 2015
Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection
Justine E Sunshine, Brendan B Larsen, Brandon Maust, et al.
The Journal of Antimicrobial Chemotherapy
|
November 25, 2010
Efavirenz concentrations in CSF exceed IC50 for wild-type HIV
Brookie M Best, Peter P Koopmans, Scott L Letendre, et al.
Page
of 51
Search research articles
Search
Showing results (411-420 of 508) with videos related to
Sort By:
Page
of 51
Plos Genetics
|
September 16, 2016
The Genetic Basis of Host Preference and Resting Behavior in the Major African Malaria Vector, Anopheles arabiensis
Bradley J Main, Yoosook Lee, Heather M Ferguson, et al.
Plos Pathogens
|
April 21, 2017
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation
Rajesh T Gandhi, Deborah K McMahon, Ronald J Bosch, et al.
American Journal of Epidemiology
|
September 18, 1999
Risk factors for HIV-1 shedding in semen
C E Speck, R W Coombs, L A Koutsky, et al.
Journal of Neuro-Aids
|
January 1, 1996
Neurologic Manifestations<br />of HIV Infection Without AIDS:Follow-UP of a Cohort<br />of Homosexual and Bisexual Men
C M Marra, W T Longstreth, H H Handsfield, et al.
Plos One
|
May 19, 2010
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection
Eric S Rosenberg, Barney S Graham, Ellen S Chan, et al.
The New England Journal of Medicine
|
April 18, 1996
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group
A C Collier, R W Coombs, D A Schoenfeld, et al.
The Journal of Infectious Diseases
|
August 23, 2003
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease
Margaret A Fischl, Heather J Ribaudo, Ann C Collier, et al.
The Journal of Infectious Diseases
|
August 11, 1998
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data
J P Ioannidis, A C Collier, D A Cooper, et al.
Journal of Virology
|
July 31, 2015
Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection
Justine E Sunshine, Brendan B Larsen, Brandon Maust, et al.
The Journal of Antimicrobial Chemotherapy
|
November 25, 2010
Efavirenz concentrations in CSF exceed IC50 for wild-type HIV
Brookie M Best, Peter P Koopmans, Scott L Letendre, et al.
Page
of 51